Efficacy of Brentuximab Vedotin and Other Treatments in Patients with Relapsed or Refractory (RR) Systemic Anaplastic Large-Cell Lymphoma (SALCL)- A Systematic Review
Abstract
Authors
V. Bonthapally H. Yang A.R. Macalalad E.Q. Wu R. Lutes O. Shonukan A. Chi D. Huebner